The effect of food intake on the pk of rhein released from diacerein

The effect of food intake on the pk of rhein released from diacerein

Diacerein is a symptomatic slow-acting drug used for treating osteoarthritis. This drug is completely metabolized into the active metabolite rhein before reaching the systemic circulation. This study evaluated the effects of food on the pharmacokinetics of rhein released from diacerein in healthy Ch...

Full description

Bibliographic Details
Main Authors:	Ming Huang, Shun-lin Zong, Quan-ying Zhang
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2020-04-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Diacerein capsule/pharmacokinetics HPLC-MS/MS High fat and calories diet
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100544&tlng=en

Similar Items

Diacerein, its beneficial impact on chondrocytes and notable new clinical applications
by: Daljit Kaur, et al.
Published: (2019-04-01)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
by: Michael Ablinger, et al.
Published: (2018-11-01)

Validated determination of diacerein and its active metabolite, rhein, by stability indicating constant pattern method as a novel manipulation of zero order spectra
by: Aml A. Emam, et al.
Published: (2018-06-01)

Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01)

Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation
by: Allam AN, et al.
Published: (2017-07-01)

Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats
by: Basma Mostafa Zaki, et al.
Published: (2015-09-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

Comparison Of Diacerein-Ginger With Diacerein Alone In Treating Knee Osteoarthritis
by: Mehtab Munir, et al.
Published: (2019-12-01)

Diacerein in the treatment of chronic musculoskeletal pain
by: E. Yu. Polishchuk, et al.
Published: (2022-06-01)

Diacerein: A New Disease Modulating Agent in Osteoarthritis
by: Medhi B, et al.
Published: (2007-10-01)

Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01)

PREPARATION AND CHARACTERIZATION OF CO-CRYSTALS OF DIACEREIN
by: Raju Rameshrao Thenge, et al.
Published: (2017-01-01)

Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation
by: Diana E. Aziz, et al.
Published: (2018-01-01)

Determination of Picogram Levels of Diacerein in a Pharmaceutical Formulation by Flow-Injection Chemiluminescence
by: Gao Suya, et al.
Published: (2017-01-01)

Atorvastatin and diacerein reduce insulin resistance and increase disease tolerance in rats with sepsis
by: K. L. C. da Silva, et al.
Published: (2018-05-01)

Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1
by: Mohd Zahoor ul haq Shah, et al.
Published: (2024-07-01)

The Effect of Dihydromyricetin on the Pharmacokinetics of Fluconazole in Sprague-Dawley Rat Plasma, Based on High-Performance Liquid Chromatography–Tandem Mass Spectrometry
by: Liu H, et al.
Published: (2023-08-01)

Bioequivalence and Pharmacokinetics of Two Formulations of Amlodipine Tablets in Healthy Subjects
by: Jaafar J. Ibraheem Al-Tamimi
Published: (2017-02-01)

Renoprotective effect of diacerein in rats with partial unilateral ureteral obstruction model
by: Kölükçü Engin, et al.
Published: (2024-04-01)

Diacerein for osteoarthritis: An open-label comparative trial
by: L. V. Luchikhina, et al.
Published: (2016-03-01)

Development of composition and evaluation of equivalence of diacerein hard gelatin capsules
by: O. O. Saliy, et al.
Published: (2021-12-01)

DIACEREIN AS THE DRUG OF CHOICE IN THE THERAPY OF KNEE OSTEOARTHRITIS WITH SECONDARY RECURRENT SYNOVITIS
by: M. I. Udovika
Published: (2016-02-01)

LC-MS/MS assisted pharmacokinetic and tissue distribution study of ropivacaine and 3-OH-ropivacaine on rats after plane block anesthesia
by: Mihaela Butiulca, et al.
Published: (2025-01-01)

Rapid and sensitive quantification of efavirenz in rat plasma using HPLC-MS/MS method
by: Leandro Tasso, et al.
Published: (2024-01-01)

A Validated HPLC-MS/MS Assay for 14-<i>O</i>-[(4,6-Diaminopyrimidine-2-yl)thioacetyl] Mutilin in Biological Samples and Its Pharmacokinetic, Distribution and Excretion via Urine and Feces in Rats
by: Yunxing Fu, et al.
Published: (2019-02-01)

Natural Deep Eutectic Solvents (NADES) to Enhance Berberine Absorption: An In Vivo Pharmacokinetic Study
by: Stefania Sut, et al.
Published: (2017-11-01)

Prediction of diacerein inhibition activity against interleukin-1 receptors through docking method and tracing of pharmacokinetic profiles and their toxicity
by: Frengki Frengki, et al.
Published: (2020-11-01)

Use of diacerein for the treatment of large joint osteoarthritis (A review of literature and the author’s own experience)
by: Rimma Mikhailovna Balabanova
Published: (2015-09-01)

Pleiotropic effects of diacerein in comorbid patients with osteoarthritis
by: I. B. Belyaeva, et al.
Published: (2022-08-01)

Diacerein the treatment of osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2016-12-01)

Identification and pharmacokinetics of saponins in Rhizoma Anemarrhenae after oral administration to rats by HPLC-Q-TOF/MS and HPLC-MS/MS
by: Wang Hai-Qiao, et al.
Published: (2021-12-01)

In vitro antibiofilm and bacteriostatic activity of diacerein against Enterococcus faecalis
by: Chunyan Fu, et al.
Published: (2023-08-01)

EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS
by: E. P. Sharapova, et al.
Published: (2017-12-01)

Natural Deep Eutectic Solvents (NADES) as a Tool for Bioavailability Improvement: Pharmacokinetics of Rutin Dissolved in Proline/Glycine after Oral Administration in Rats: Possible Application in Nutraceuticals
by: Marta Faggian, et al.
Published: (2016-11-01)

Comparative Pharmacokinetics of Cinobufacini Capsule and Injection by UPLC-MS/MS
by: Ming Li, et al.
Published: (2022-07-01)

Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS
by: Zhu Y, et al.
Published: (2024-07-01)

Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats
by: Yutao Lou, et al.
Published: (2023-08-01)

PHARMACOKINETIC STUDIES DERIVED INDOLE SS-68 WITH ANTIARRHYTHMIC AND ANTIANGINAL PROPERTIES
by: Pavel Galenko-Yaroshevsky, et al.
Published: (2016-06-01)

Determination of Dapoxetine Hydrochloride in Human Plasma by HPLC–MS/MS and Its Application in a Bioequivalence Study
by: Xin Zhang, et al.
Published: (2022-04-01)